127 related articles for article (PubMed ID: 32376321)
1. Relationship between the plasma acylcarnitine profile and cardiometabolic risk factors in adults diagnosed with cardiovascular diseases.
Kukharenko A; Brito A; Kozhevnikova MV; Moskaleva N; Markin PA; Bochkareva N; Korobkova EO; Belenkov YN; Privalova EV; Larcova EV; Ariani A; La Frano MR; Appolonova SA
Clin Chim Acta; 2020 Aug; 507():250-256. PubMed ID: 32376321
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
[No Abstract] [Full Text] [Related]
3. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
Davies A; Wenzl FA; Li XS; Winzap P; Obeid S; Klingenberg R; Mach F; Räber L; Muller O; Matter CM; Laaksonen R; Wang Z; Hazen SL; Lüscher TF
Int J Cardiol; 2023 Oct; 389():131261. PubMed ID: 37574027
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum.
Wang M; Yang R; Dong J; Zhang T; Wang S; Zhou W; Li H; Zhao H; Zhang L; Wang S; Zhang C; Chen W
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():144-51. PubMed ID: 26735710
[TBL] [Abstract][Full Text] [Related]
5. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
[TBL] [Abstract][Full Text] [Related]
6. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS.
Silva MF; Selhorst J; Overmars H; van Gennip AH; Maya M; Wanders RJ; de Almeida IT; Duran M
Clin Biochem; 2001 Nov; 34(8):635-8. PubMed ID: 11849623
[TBL] [Abstract][Full Text] [Related]
7. Association between resistance to erythropoiesis-stimulating agents and carnitine profile in patients on maintenance haemodialysis.
Kamei D; Tsuchiya K; Nitta K; Mineshima M; Akiba T
Nephrology (Carlton); 2018 Aug; 23(8):737-743. PubMed ID: 28608940
[TBL] [Abstract][Full Text] [Related]
8. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.
Ruiz M; Labarthe F; Fortier A; Bouchard B; Thompson Legault J; Bolduc V; Rigal O; Chen J; Ducharme A; Crawford PA; Tardif JC; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H768-H781. PubMed ID: 28710072
[TBL] [Abstract][Full Text] [Related]
9. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.
Kriisa K; Leppik L; Balõtšev R; Ottas A; Soomets U; Koido K; Volke V; Innos J; Haring L; Vasar E; Zilmer M
J Proteome Res; 2017 Oct; 16(10):3558-3566. PubMed ID: 28786289
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
Roy C; Tremblay PY; Bienvenu JF; Ayotte P
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
[TBL] [Abstract][Full Text] [Related]
11. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
[TBL] [Abstract][Full Text] [Related]
12. [Blood spot carnitine and acylcarnitine in newborn to adolescence: measured by tandem mass spectrometry].
Gong ZH; Tian GL; Wang YM
Zhonghua Er Ke Za Zhi; 2010 Dec; 48(12):922-7. PubMed ID: 21215187
[TBL] [Abstract][Full Text] [Related]
13. Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol.
Weng L; Gong Y; Culver J; Gardell SJ; Petucci C; Morse AM; Frye RF; Turner ST; Chapman A; Boerwinkle E; Gums J; Beitelshees AL; Borum PR; Johnson JA; Garrett TJ; McIntyre LM; Cooper-DeHoff RM
Metabolomics; 2016 Oct; 12(10):. PubMed ID: 28217401
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
Chalmers RA; Roe CR; Stacey TE; Hoppel CL
Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
[TBL] [Abstract][Full Text] [Related]
17. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study.
Moreno FA; Macey H; Schreiber B
J Clin Psychiatry; 2005 May; 66(5):555-8. PubMed ID: 15986510
[TBL] [Abstract][Full Text] [Related]
18. Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients.
Miyaaki H; Kobayashi H; Miuma S; Fukusima M; Sasaki R; Haraguchi M; Nakao K
BMC Gastroenterol; 2020 Feb; 20(1):41. PubMed ID: 32075591
[TBL] [Abstract][Full Text] [Related]
19. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography.
Minkler PE; Hoppel CL
Anal Biochem; 1993 Aug; 212(2):510-8. PubMed ID: 8214594
[TBL] [Abstract][Full Text] [Related]
20. Human forearm arteriovenous differences of carnitine, short-chain acylcarnitine and long-chain acylcarnitine.
Bartlett K; Bhuiyan AK; Aynsley-Green A; Butler PC; Alberti KG
Clin Sci (Lond); 1989 Oct; 77(4):413-6. PubMed ID: 2805599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
